Clinical trials: Blincyto Use in Routine Clinical Practice
- Condition Blincyto Use in Routine Clinical Practice
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Blincyto Use in Routine Clinical Practice
Observational Study of Blinatumomab
An observational study of blinatumomab safety and effectiveness, utilisation, and treatment practices.
- Trial name
- NCT03117621
- Where
- 80 sites in Austria, Czechia and 11 more
- Volunteers
- 279 people
- Sponsor
- Amgen